Identification of an age-related defect in glucose-stimulated insulin secretion in non-diabetic women

Endocrinology and Metabolism, Supplement

Volumn 4, Issue 3, 1997, Pages 193-200

  Jones, Clare N O ^a   Pei, Dee ^a   Sturis, Jeppe ^a   Polonsky, Kenneth S ^a   Chen, Y D Ida ^a   Reaven, Gerald M ^a  

^a Shaman Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE INFUSION; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; PRIORITY JOURNAL;

EID: 0030853213     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Harris MI, Hades WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 2-74 years. Diabetes 1987; 36: 423-434.
2. Kane RL, Solomon DH, Beck JC, Keeler EB, Kane RD. Geriatrics in the United States. Lexington, MA: Lexington Books, 1981: 9-16.
3. Reaven GM, Miller R. Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 1968; 17: 560-569.
4. Saad MF, Pettitt DJ, Mott DM, Knowler WC, Nelson RG, Bennett PH. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1989; 1: 1356-1359.
5. Sicree RA, Zimmet PZ, King HOM, Coventry JS. Plasma insulin response among Nauruans: Prediction of deterioration in glucose tolerance over 6 yr. Diabetes 1968; 36: 179-186.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
7. Reaven EP, Gold G, Reaven GM. Effect of age on glucose-stimulated insulin release by the β-cell of the rat. J. Clin. Invest. 1979; 64: 591-599.
8. Reaven EP, Reaven GM. Structure and function changes in the endocrine pancreas of aging rats with reference to the modulating effects of exercise and caloric restriction. J. Clin. Invest. 1981; 68: 75-84.
9. Reaven E, Curry D, Moore J, Reaven GM. Effect of age and environmental factors on insulin release from the perfused pancreas of the rat. J. Clin. Invest. 1983; 71: 345-350.
10. Reaven E, Wright D, Mondon CE, Solomon R, Ho H, Reaven GM. Effect of age and diet on insulin secretion and insulin action in the rat. Diabetes 1983; 32: 175-180.
11. Curry DL, Reaven GM, Reaven E. Glucose-induced secretion by perfused pancreas of 2- and 12-mo-old Fischer 344 rats. Am. J. Physiol. 1984; 247 (Endocrinol. Metab. 10): E385-E388.
12. Reaven EP, Curry DL, Reaven GM. Effect of age and sex on rat endocrine pancreas. Diabetes 1987; 36: 1397-4000.
13. Maclean N, Ogilvie RF. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 1955; 4: 367-376.
14. Davidson MD. The effect of aging on carbohydrate metabolism. A review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 1979; 28: 688-705.
15. Reaven GM, Reaven E. Insulin and glucose metabolism during aging. In: Adelman RC, Roth GS, editors, Endocrine and Neuroendocrine Mechanisms of Aging. Boca Raton: CRC Press, Inc., 1982: 1-14.
16. Reaven GM, Reaven E. Age, glucose intolerance, and non-insulin-dependent diabetes mellitus. J. Am. Geriatr. Soc. 1985; 33: 286-290.
17. Rowe JW, Minnaker KL, Pallotta JA, Flier JS. Characterization of the insulin resistance of aging. J. Clin. Invest. 1983; 71: 1581-1587.
18. Fink RI, Wallace P, Olefsky JM. Effects of aging on glucose-mediated glucose disposal and glucose transport. J. Clin. Invest. 1986; 77: 2034-2041.
19. Reaven GM, Chen N, Hollenbeck C, Chen Y-DI. Effects of age on glucose tolerance and glucose uptake in healthy individuals. J. Am. Geriatr. Soc. 1989; 37: 735-740.
20. Byrne MM, Sturis J, Clement K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI, Velho G, Froguel P, Polonsky KS. Insulin secretion abnormalities in subjects with hyperglycemia due to glucokinase mutations. J. Clin. Invest. 1994; 93: 1120-1130.
21. Kadish AH, Litle RH, Sternberg JC. A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin. Chem. 1968; 14: 116-131.
22. Hales CN, Randle PJ. Immunoassay of insulin with insulin-antibody precipitate. Biochem. J. 1963; 88: 137-146.
23. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
24. Shen S-W, Reaven GM, Farquhar J. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J. Clin. Invest. 1970; 49: 2151-2160.
25. Shen D-C, Shieh S-M, Fuh M-T, Wu D-A, Chen Y-DI, Reaven GM. Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J. Clin. Endocrinol. Metab. 1988; 66: 580-583.
26. Byrne MM, Sturis J, Polonsky K. Insulin secretion and clearance during low-dose graded glucose infusion. Am. J. Physiol. 1995; 268: E21-E27.
27. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B. Use of biosynthetic C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J. Clin. Invest. 1986; 77: 98-105.
28. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard parameters for C-peptide clearance. Diabetes 1992; 41: 368-377.
29. Godfrey K. Statistics in practice. Comparing the means of several groups. N. Engl. J. Med. 1985; 313: 1450-1456.
30. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel Procedure. J. Am. Statistical Assoc. 1963; 58: 690-700.
31. Chen M, Bergman RN, Pacini G, Porte D Jr. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function. J. Clin. Endocrinol. Metab. 1985; 60: 13-20.
32. Gumbiner B, Polonsky KS, Beltz WF, Wallace P, Brechtel G, Fink RI. Effects of aging on insulin secretion. Diabetes 1989; 38: 1549-1556.
33. Palmer JP, Einsinck JW. Acute-phase insulin secretion and glucose tolerance in young and aged normal men and diabetic patients. J. Clin. Endocrinol. Metab. 1975; 41: 498-503.
34. Dudl RJ, Ensinck JW. Insulin and glucagon relationships during aging in man. Metabolism 1977; 26: 33-41.
35. Pacini G, Valerio A, Beccaro F, Nosadini R, Cobelli C, Crepaldi G. Insulin sensitivity and beta cell responsivity are not decreased in elderly subjects with normal OGTT. J. Am. Geriatr. Soc. 1988; 36: 317-323.
36. Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, Andres R. The enteric enhancement of glucose-stimulated insulin release: The role of GIF in aging, obesity, and non-insulin-dependent diabetes mellitus. Diabetes 1984; 33: 950-957.
37. Bourey RE, Kohrt WM, Kirwan JP, Staten MA, King DS, Holloszy JO. Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. J. Gerontology 1993; 48: M122-M127.
38. Olefsky JM, Farquhar JW, Reaven GM. Do the oral and intravenous glucose tolerance tests provide similar diagnostic information in patients with chemical diabetes mellitus? Diabetes 1973; 22: 202-209.